| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,311 | 15,340 | 13,536 | 14,782 | | Cost of Revenue | 7,554 | 8,400 | 8,200 | 8,128 | | | Gross Profit | 8,757 | 6,940 | 5,336 | 6,654 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,474 | 1,436 | 1,473 | 1,603 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,895 | 1,449 | 1,633 | 1,731 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,059 | 4,055 | 2,230 | 3,320 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,523 | 168 | 90 | 143 | | Earnings Before Interest And Taxes | 5,582 | 4,230 | 2,313 | (55) | | Interest Expense | 1,215 | 1,117 | 1,169 | 1,397 | | Income Before Tax | 4,367 | 3,113 | 1,144 | (1,452) | | Income Tax Expense | 785 | 840 | 7 | 133 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,582 | 2,266 | 1,144 | 1,933 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,759 | 2,266 | 1,144 | 1,933 | | Preferred Stock And Other Adjustments | (10) | (10) | (9) | (9) | | | Net Income Applicable To Common Shares | $5,749 | $2,256 | $1,135 | $1,924 |
|
0.51% Nasdaq 
Income Statement
